Skip to content
PPD Inc
Main Menu
  • Blog
  • Careers
  • Contact Us
  • Investors
  • News
  • Preclarus
  • Japan
Search
  • Who We Are
    • Our Mission
      • Accolades
      • Company History
    • Defining Principles
    • Our People
      • Board of Directors
    • Senior Leadership
    • Our Work
      • Our Solutions
      • How We Help
      • Therapeutic Areas
    • Corporate Responsibility
      • Environmental Stewardship
      • Health and Wellness
      • Philanthropy
      • PPD Heroes
    • Locations
    • Company Resources
      • Ethics
      • Events
      • Investors
      • Media Kit
      • PPD in the News
      • Legal Notices
      • Privacy Policy
      • Vendor Resources
  • How We Help
    • Building Patient-Driven Trials
    • Clinical Trial Certainty/Reliability
    • COVID-19
    • Digital Trials
    • Expertise in Asia-Pacific
    • Leveraging Identified Data
    • Supporting Product Approval
    • PPD Biotech
      • Resources
  • Our Solutions
    • Clinical Development
      • Early Development
        • Phase I
      • Phase II-IV Clinical Trial Management
        • Biostatistics
        • Clinical Trial Monitoring
        • Clinical Data Management
        • Global Clinical Supplies
        • Interactive Response Technology (IRT)
        • Medical Communications
        • Medical Writing
        • Pharmacokinetic and Pharmacodynamic
        • Pharmacovigilance
        • Project Management
      • Peri- and Post-approval
        • Data and Real-World Evidence
        • Evidence Synthesis, Modeling and Communication
        • Interventional Studies
        • Non-Interventional Studies
      • PPD Biotech
      • PPD FSP
        • PPD FSP Source
      • Product Development and Consulting
      • Quality and Enterprise Learning
      • Regulatory Affairs
      • Site and Patient-centric Solutions
        • Accelerated Enrollment Solutions (AES)
        • Enrollment and Site Activation
        • Integrating the Patient Voice
        • Leveraging Technology
        • PatientAdvantage
        • Reducing Patient Burden
        • Contact Site and Patient Services
      • Technology and Innovation
        • Business Process and Change Management
        • Global Technology Services
        • Preclarus
        • Products and Services
      • Government and Public Health
      • Medical Device Development
    • PPD Laboratories
      • Bioanalytical Lab
        • Capabilities
        • Experience and Expertise
        • PPD® Laboratories’ Tech Talks
      • Biomarker Lab
        • Capabilities
      • Central Lab
        • Capabilities
        • Certifications
        • Preclarus
        • Preclarus lab portals
        • PBMC Processing Services
      • GMP Lab
        • Capabilities
        • Experience and Expertise
      • Vaccine Sciences Lab
        • Capabilities
      • PPD Laboratories FSP
      • Part of the COVID-19 Solution
  • Therapeutic Areas
    • Cardiovascular
    • Critical Care
    • Dermatology
    • Gastroenterology
    • Immunology and Rheumatology
    • Infectious Diseases
    • Metabolic and Endocrine
    • Neuroscience
    • Oncology and Hematology
    • Ophthalmology
    • Pediatrics
    • Rare Diseases
    • Respiratory
    • Urology
    • Vaccine Development
    • Women’s Health
  • Participate in a Trial
    • Austin Clinical Research Unit
      • Volunteer Opportunities
      • Who can be a volunteer
      • What to Expect
      • Online Tour
      • Study Volunteer FAQ
      • Contact Information
    • Las Vegas Clinical Research Unit
      • Volunteer Opportunities
      • Who can be a volunteer
      • What to Expect
      • Online Tour
      • Study Volunteer FAQ
      • Contact Information
    • Orlando Clinical Research Unit
    • Phase II-IIIb Clinical Trial Volunteers
    • Become a Clinical Trial Investigator
      • Advantages of Being a Clinical Trial Investigator
      • FAQ
      • SiteCoach
      • Process
      • Informed Consent
      • IRB
      • Clinical Trial Investigators Database Registration
hex

Ligand-binding Assays (LBA) vs. Liquid Chromatography-Mass Spectrometry (LC-MS) for Biologics

Our SolutionsPPD LaboratoriesBioanalytical LabBioA Experience and ExpertiseBioanalytical Lab Thought Leadership SeriesLigand-binding Assays (LBA) vs. Liquid Chromatography-Mass Spectrometry (LC-MS) for Biologics

Bill Mylott, director of biologics by LC-MS at our bioanalytical lab, discusses different approaches to use for biologics studies.

Watch the video below.

  • Legal Notices
  • Site Map
  • Modern Slavery Transparency Statement
  • Privacy Policy
©2020 PPD Inc. All Rights Reserved.
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • Contact Us

PPD uses cookies on this website. Please be aware that if you continue browsing the website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.